Zydus Life Vadodara Unit Receives 4 USFDA Observations
Shares of Zydus Lifesciences Ltd were trading in the green and almost 1% higher on 8 September despite the company’s Vadodara unit receiving 4 observations...
Tag : US Food & Drug Administration (USFDA)
SMS Pharma Shares Skyrocket 10% on EIR from USFDA
Shares of SMS Pharmaceuticals Ltd skyrocketed more than 10% on Thursday, 28 August, after the company received an Establishment Inspection Report (EIR) with a No...
Biocon Shares Trade 1% Higher as Arm Secures USFDA Approval
Shares of Biocon Ltd gained 1% on 28 August after the company announced securing USFDA approval for Sitagliptin Tablets. In its regulatory filing, the company...
Alembic Pharma Shares Trade 2% Higher on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd increased 2% on Tuesday, 19 August 2025, on securing a final approval from the USFDA. Alembic Pharmaceuticals gained final approval...
Alembic Pharma Shares Up 2% on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rose more than 2% on Monday, 18 August, after the company announced that it had achieved final USFDA approval. In...
Alembic Pharma Shares Surge 2% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd surged more than 2% on 28 July after the company announced securing final approval from the USFDA for Carbamazepine Extended-Release...
Dr Reddy’s Secured EIR for New York API Facility; Shares Slump 1%
Shares of Dr Reddy’s Laboratories Ltd were trading in the red and 1% lower on 22 July despite the company announcing it had obtained the...
Lupin Shares Gain 1% on USFDA Approval
Shares of Lupin Ltd were trading in the green and 1% higher on 2 July after the company announced receiving approval from the USFDA for...
Alembic Pharma Shares Skyrocketed 14% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd skyrocketed more than 14% on 30 June after the company announced on Sunday that it had received final USFDA approval...
SMS Pharma Shares Surge 6% on 0 Observations from USFDA
Shares of SMS Pharmaceuticals Ltd surged 6% on 26 June after the company announced receiving no observations from the US Food and Drug Administration (USFDA)....